by Jordana Choucair | Apr 11, 2022 | D.C. News
Several members of President Biden’s cabinet are among at least 67 people known to have contracted COVID-19 after attending the Gridiron Club dinner in Washington, D.C. On Sunday, Dr. Anthony Fauci said there is no particular reason to fear that President Joe...
by Jordana Choucair | Apr 11, 2022 | Opioid/Substance Use Disorders
The Centers for Disease Control and Prevention (CDC) is expected to release updated guidelines regarding opioid prescribing practices. The proposed guidelines include some notable changes: they no longer include specific limits on the dose and duration of an opioid...
by Jordana Choucair | Apr 11, 2022 | Public Health/Prevention
Health experts are warning that preparations for future public health emergencies must include chronic diet-related illnesses, including those stemming from the obesity crisis. The COVID-19 pandemic demonstrated that Americans were more vulnerable to serious illness...
by Jordana Choucair | Apr 11, 2022 | Payers
A recent study from Humana highlights how seniors faced common challenges related to social determinants of health (SDOH) and inequities before the onset of the COVID-19 pandemic. The study found that 49.3 of the more than 100,000 Medicare Advantage (MA) members...
by Jordana Choucair | Apr 8, 2022 | Access & Coverage
A new analysis from the Robert Wood Johnson Foundation estimates that 3.1 million Americans will lose health coverage if Congress doesn’t extend enhanced Affordable Care Act (ACA) subsidies. A disproportionate share of young adults, low-income people, and...
by Jordana Choucair | Apr 8, 2022 | Payers
Medicare will cover the Alzheimer’s drug Aduhelm only for clinical trials, despite the Food and Drug Administration (FDA) approving the drug for some 1.5 million people. Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure said the...
Recent Comments